- Home
- CMRX vs HAIN Comparison
CMRX vs HAIN Comparison
Compare CMRX & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- HAIN
- Stock Information
- Founded
- CMRX 2000
- HAIN 1993
- Country
- CMRX United States
- HAIN United States
- Employees
- CMRX N/A
- HAIN N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- HAIN Packaged Foods
- Sector
- CMRX Health Care
- HAIN Consumer Staples
- Exchange
- CMRX Nasdaq
- HAIN Nasdaq
- Market Cap
- CMRX 394.1M
- HAIN 445.6M
- IPO Year
- CMRX 2013
- HAIN 1993
- Fundamental
- Price
- CMRX $5.15
- HAIN $4.18
- Analyst Decision
- CMRX Strong Buy
- HAIN Hold
- Analyst Count
- CMRX 2
- HAIN 8
- Target Price
- CMRX $8.50
- HAIN $6.56
- AVG Volume (30 Days)
- CMRX 1.7M
- HAIN 2.0M
- Earning Date
- CMRX 03-07-2025
- HAIN 02-10-2025
- Dividend Yield
- CMRX N/A
- HAIN N/A
- EPS Growth
- CMRX N/A
- HAIN N/A
- EPS
- CMRX N/A
- HAIN N/A
- Revenue
- CMRX $159,000.00
- HAIN $1,663,238,000.00
- Revenue This Year
- CMRX N/A
- HAIN N/A
- Revenue Next Year
- CMRX $1,690.28
- HAIN $2.22
- P/E Ratio
- CMRX N/A
- HAIN N/A
- Revenue Growth
- CMRX N/A
- HAIN N/A
- 52 Week Low
- CMRX $0.75
- HAIN $3.28
- 52 Week High
- CMRX $5.53
- HAIN $10.07
- Technical
- Relative Strength Index (RSI)
- CMRX 76.25
- HAIN 36.49
- Support Level
- CMRX $3.94
- HAIN $3.87
- Resistance Level
- CMRX $5.53
- HAIN $4.60
- Average True Range (ATR)
- CMRX 0.30
- HAIN 0.37
- MACD
- CMRX 0.07
- HAIN 0.00
- Stochastic Oscillator
- CMRX 78.29
- HAIN 50.28
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.